← Leaderboards
Sharon Tamir
Karyopharm Therapeutics, Inc.
$608,756
Attributed
$1,217,511
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $992.5K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NIH$1,217,511 · 2
By mechanism
R44$992,511 · 1
R43$225,000 · 1
Top collaborators
- Yosef Landesman1 shared
- Margaret S Lee1 shared
Most similar at Karyopharm Therapeutics, Inc.
Same institution · by research overlap
- Yosef Landesman$987,461
- Margaret S Lee$112,500
- Douglas G. Widman$491,206
Others in their field
Top investigators on “African American”
- Daniel C Ralph · Cornell University$89,901,072
- Roger T Howe · University Of California-Berkeley$89,901,072
- James D Crapo · University Of Colorado Denver$80,593,932
- Laurence H Baker · University Of Michigan At Ann Arbor$80,299,268
- William J. Blot · Vanderbilt University$71,101,682
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$70,204,880
Research focus
African AmericanAntibodiesAnti-InflammatoryAnti-Inflammatory AgentsAttentionAutoimmune DiseasesAutoimmunityB-LymphocytesCellsChemokineClinical TrialsCollaborationsComplexCritical PathwaysCytokineCytokine SignalingDialysis ProcedureDoseDs-DnaExhibitsFundingGenerationsHeadAffect